Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed3
Recruiting1
Terminated1
Other3

Role Distribution

Principal Investigator7
Other Roles1
PI Rate88%

Activity Timeline

Clinical Trials (8)

NCT06171217Phase 2Active Not Recruiting
Realizing Effectiveness Across Continents With Hydroxyurea
ChildrenSickle Cell Disease
PrincipalinvestigatorStart date: 2023-10-27
NCT05662098Early Phase 1Active Not Recruiting
Alternative Dosing And Prevention of Transfusions (ADAPT)
Sickle Cell Disease
StudydirectorStart date: 2022-06-16
NCT04566965Terminated
Serology to COVID-19 for Recording Exposures and Evaluating Needs
CoronavirusCovid19SARS-CoV Infection
PrincipalinvestigatorStart date: 2020-08-18
NCT04472793Completed
Repeated Employee Testing for Understanding Our Recovery to Normal
COVID-19
PrincipalinvestigatorStart date: 2020-05-11
NCT02990598Completed
Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)
Sickle Cell Anemia
PrincipalinvestigatorStart date: 2017-03-20
NCT02769845Not ApplicableCompleted
SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
Sickle Cell Anemia
PrincipalinvestigatorStart date: 2016-03-16
NCT06301893Recruiting
Uganda Sickle Surveillance Study (US-3)
Sickle Cell Disease
PrincipalinvestigatorStart date: 2013-09-07
NCT01966731Phase 1/2Active Not Recruiting
Realizing Effectiveness Across Continents With Hydroxyurea (REACH)
Sickle Cell Disease
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Children's Hospital Medical Center, Cincinnati

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Allen Staat, MD, MPH

Children's Hospital Medical Center, Cincinnati

Moderately Similar
2 trials

Shared therapeutic areas:

COVID-19CoronavirusSARS-CoV Infection

Worked with same sponsors:

Children's Hospital Medical Center, Cincinnati
Collaborated on 2 trials
Similarity Score38%

Sue Poynter Wong, MD, MEd

Children's Hospital Medical Center, Cincinnati

Moderately Similar
1 trials

Shared therapeutic areas:

CoronavirusCOVID-19SARS-CoV Infection

Worked with same sponsors:

Children's Hospital Medical Center, Cincinnati
Collaborated on 1 trial
Similarity Score34%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19CoronavirusSARS-CoV Infection
Similarity Score18%

Grace Ndeezi, MBChB, MMed, PhD

Department of Pediatrics & Child Health College of Health Sciences Makerere University

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle Cell

Worked with same sponsors:

Children's Hospital Medical Center, CincinnatiMakerere University+2 more
Collaborated on 1 trial
Similarity Score14%

John F Tisdale, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
17 trials

Shared therapeutic areas:

Anemia, Sickle Cell

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score6%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Anemia, Sickle Cell
Similarity Score6%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Child
Similarity Score6%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score6%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Anemia, Sickle Cell

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score6%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT06171217Phase 2PrincipalInvestigator

Realizing Effectiveness Across Continents With Hydroxyurea

ChildrenSickle Cell Disease
Active Not Recruiting
NCT05662098Early Phase 1StudyDirector

Alternative Dosing And Prevention of Transfusions (ADAPT)

Sickle Cell Disease
Active Not Recruiting
NCT04566965PrincipalInvestigator

Serology to COVID-19 for Recording Exposures and Evaluating Needs

CoronavirusCovid19SARS-CoV Infection
Terminated
NCT04472793PrincipalInvestigator

Repeated Employee Testing for Understanding Our Recovery to Normal

COVID-19
Completed
NCT02990598PrincipalInvestigator

Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)

Sickle Cell Anemia
Completed
NCT02769845Not ApplicablePrincipalInvestigator

SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia

Sickle Cell Anemia
Completed
NCT06301893PrincipalInvestigator

Uganda Sickle Surveillance Study (US-3)

Sickle Cell Disease
Recruiting
NCT01966731Phase 1/2PrincipalInvestigator

Realizing Effectiveness Across Continents With Hydroxyurea (REACH)

Sickle Cell Disease
Active Not Recruiting

All 8 trials loaded